Clinical Trials Browser

Phase 1/2 × Advanced Solid Tumors × durvalumab × Clear all

NCT01693562 2021-05-13

A Phase 1/2 Study to Evaluate MEDI4736

Phase 1/2 Completed

1,022 enrolled 42 charts

Other solid neoplasm

Advanced Solid Tumors